Integra Lifesciences Holdings Corp (IART) earnings
Quarterly results of Integra Lifesciences Holdings Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Integra Lifesciences Holdings Corp is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Integra Lifesciences Holdings Corp reported revenue of $411.2M (+2.3% on the same quarter a year earlier) and net income of $14.9M.
Diluted earnings per share were $0.19.
The latest results release
Integra LifeSciences announced preliminary third-quarter financial results and lowered its full-year 2026 outlook due to supply disruptions from flooding at its Cincinnati facility.
Preliminary third-quarter reported revenue is expected to be between $410 million to $412 million, and adjusted earnings per diluted share is expected to be $0.55 to $0.59.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $411.2M | +2.3% | $14.9M | $0.19 |
| Q2 FY2026 | $418.8M | +0.8% | $4.5M | $0.06 |
| Q1 FY2026 | $391.9M | +2.4% | -$4.6M | -$0.06 |
| Q4 FY2025 | $434.9M | -1.7% | -$1.7M | - |
| Q3 FY2025 | $402.1M | - | -$5.4M | -$0.07 |
| Q2 FY2025 | $415.6M | - | -$484.1M | -$6.31 |
| Q1 FY2025 | $382.7M | - | -$25.3M | -$0.33 |
| Q4 FY2024 | $442.6M | - | $19.4M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Integra Lifesciences Holdings Corp's next earnings date?
Integra Lifesciences Holdings Corp is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Integra Lifesciences Holdings Corp's latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Integra Lifesciences Holdings Corp reported revenue of $411.2M and net income of $14.9M. The figures come from its filing with the SEC.
Is Integra Lifesciences Holdings Corp's revenue growing?
Revenue in Q3 FY2026 was $411.2M, up 2.3% from $402.1M in the same quarter a year earlier.
Get an email when IART reports
Follow IART and we email you its next results the day they are filed, with the numbers explained.